Total Payments
$1.1M
2024 Payments
$135,860
Companies
30
Transactions
885
Medicare Patients
325
Medicare Billing
$31,487
Payment Breakdown by Category
Consulting$609,249 (53.8%)
Other$393,621 (34.8%)
Travel$95,152 (8.4%)
Food & Beverage$25,928 (2.3%)
Research$7,349 (0.6%)
Education$228.85 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $609,249 | 124 | 53.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $366,996 | 68 | 32.4% |
| Travel and Lodging | $95,152 | 238 | 8.4% |
| Honoraria | $26,625 | 7 | 2.4% |
| Food and Beverage | $25,928 | 437 | 2.3% |
| Unspecified | $7,349 | 5 | 0.6% |
| Education | $228.85 | 6 | 0.0% |
Payments by Type
General
$1.1M
880 transactions
Research
$7,349
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $504,597 | 348 | $0 (2022) |
| ABBVIE INC. | $442,671 | 236 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $88,749 | 121 | $0 (2024) |
| Lilly USA, LLC | $25,957 | 33 | $0 (2023) |
| Ipsen Innovation | $23,961 | 7 | $0 (2017) |
| EPI Health, LLC | $19,584 | 5 | $0 (2020) |
| DERMIRA, INC. | $8,523 | 9 | $0 (2019) |
| Solta Medical, a division of Bausch Health US, LLC | $7,818 | 8 | $0 (2024) |
| Aclaris Therapeutics, Inc. | $4,632 | 9 | $0 (2019) |
| Merz Pharmaceuticals GmbH | $1,577 | 19 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135,860 | 89 | ABBVIE INC. ($127,284) |
| 2023 | $323,626 | 181 | ABBVIE INC. ($310,777) |
| 2022 | $231,703 | 127 | Allergan, Inc. ($195,907) |
| 2021 | $112,996 | 101 | Allergan, Inc. ($89,571) |
| 2020 | $65,542 | 33 | Allergan, Inc. ($33,562) |
| 2019 | $73,801 | 120 | Allergan Inc. ($38,695) |
| 2018 | $80,773 | 107 | Allergan Inc. ($71,098) |
| 2017 | $107,227 | 127 | Allergan Inc. ($75,764) |
All Payment Transactions
885 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,175.00 | General |
| 12/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $587.50 | General |
| 11/27/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Consulting Fee | Cash or cash equivalent | $6,960.00 | General |
| 11/27/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $4,700.00 | General |
| 11/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $11,750.00 | General |
| 11/14/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $47.00 | General |
| 11/02/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $437.98 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $62.50 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $48.08 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 11/02/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.32 | General |
| 11/01/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $202.31 | General |
| 10/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $170.54 | General |
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Travel and Lodging | In-kind items and services | $408.56 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Travel and Lodging | In-kind items and services | $271.95 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $96.62 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $31.87 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Travel and Lodging | In-kind items and services | $29.00 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $11.98 | General |
| 10/16/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Food and Beverage | In-kind items and services | $8.20 | General |
| 10/10/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $46.88 | General |
| 09/26/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $137.58 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LONG RUN: LONGitudinal Evaluation and Real-world Evidence of Uniquely Purified incobotulinumtoxinA (Xeomin) in Treatment Naive Participants | MERZ NORTH AMERICA, INC. | $6,300 | 1 |
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,035 | 3 |
| A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence | ABBVIE INC. | $14.82 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 66 | $13,386 | $4,804 |
| 2022 | 3 | 61 | 74 | $16,926 | $6,711 |
| 2021 | 6 | 108 | 131 | $27,591 | $11,645 |
| 2020 | 6 | 99 | 184 | $21,297 | $8,327 |
Total Patients
325
Total Services
455
Medicare Billing
$31,487
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 29 | $7,360 | $2,782 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 23 | $4,140 | $1,430 | 34.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 14 | $1,886 | $591.80 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 39 | $9,933 | $3,794 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 23 | $4,209 | $1,702 | 40.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 12 | 12 | $2,784 | $1,215 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 32 | $8,352 | $3,473 | 41.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 18 | 25 | $5,775 | $2,595 | 44.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 32 | $5,888 | $2,550 | 43.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 12 | 12 | $2,544 | $1,173 | 46.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,486 | $1,039 | 41.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 16 | 19 | $2,546 | $815.95 | 32.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 28 | $6,132 | $2,366 | 38.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 16 | 26 | $5,788 | $2,327 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 28 | $4,001 | $1,627 | 40.7% |
| 17000 | Destruction of skin growth | Office | 2020 | 18 | 23 | $2,970 | $966.19 | 32.5% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 11 | 11 | $1,645 | $704.02 | 42.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 11 | 68 | $759.99 | $336.27 | 44.2% |
About Dr. Terrence Keaney, M.D
Dr. Terrence Keaney, M.D is a Dermatology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1902049489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terrence Keaney, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $135,860 received in 2024. These payments were reported across 885 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($609,249).
As a Medicare-enrolled provider, Keaney has provided services to 325 Medicare beneficiaries, totaling 455 services with total Medicare billing of $31,487. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Washington, DC
- Active Since 04/13/2009
- Last Updated 08/08/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1902049489
Products in Payments
- BOTOX (Biological) $305,566
- BOTOX COSMETIC (Biological) $39,454
- Xeomin (Biological) $31,209
- Dysport 300 U-1 (Drug) $23,961
- XEOMIN (Biological) $20,626
- Sitavig (Drug) $19,584
- Olumiant (Drug) $13,882
- OLUMIANT (Drug) $9,965
- QBREXZA (Drug) $8,503
- THERMAGE FLX $7,818
- KYBELLA (Biological) $5,914
- RHOFADE (Drug) $4,783
- ESKATA (Drug) $2,573
- Otezla (Drug) $260.38
- Impoyz (Drug) $241.64
- COSENTYX (Biological) $163.07
- SKYRIZI (Biological) $158.06
- TREMFYA (Drug) $126.73
- Humira (Biological) $100.87
- Ilumya (Biological) $95.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Washington
Dr. Jonathan Silverberg, Md, Phd, Mph, MD, PHD, MPH
Dermatology — Payments: $4.9M
Dermatology $4.9M
Dr. Adam Friedman, M.d, M.D
Dermatology — Payments: $1.8M
Dermatology $1.8M
Dr. Candrice Heath, Md, MD
Dermatology — Payments: $214,277
Dermatology $214,277
Mary Ruth Buchness, Md, MD
Dermatology — Payments: $150,119
Dermatology $150,119
Dr. Todd Perkins, Md, MD
Dermatology — Payments: $117,310
Dermatology $117,310
Dr. Yolanda Holmes, Md, MD
Dermatology — Payments: $107,834
Dermatology $107,834